How much cash does BioSig Technologies, Inc. generate?

BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.

Where does BioSig Technologies, Inc.'s cash flow data come from?

Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

BioSig Technologies, Inc. STEX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Net income	-$46.69M-1,568%	-$424.01M-38,481%	-$15.58M-714%	-$20.37M-421%	-$2.8M+18.0%
Depreciation and amortization	$1.49M+7,005%	$1.47M+4,797%	$1.49M+4,700%	$554K+1,031%	$21K-73.1%
Stock-based compensation	$25.37M+1,123%	$48.82M—	$842K-44.5%	$5.37M+21.2%	$2.07M+95.5%
Deferred income taxes	-$565K—	-$489K—	——	——	——
Change in accounts receivable	-$11K—	——	——	——	——
Change in accounts payable	$780K+241%	——	$761K+135%	$6.19M+278%	-$555K-179%
Other working capital changes	——	$0-100%	$14K-88.3%	$41K-47.4%	$41K-46.8%
Change in prepaid expenses	$1.93M+2,663%	——	$1.99M+3,998%	——	$70K—
Net gains (losses) on investments	$2.94M—	——	——	——	——
Loss on extinguishment of debt	-$3.06M-6,339%	$49K-92.2%	$49K-92.2%	$49K-92.2%	$49K-92.2%
Change in operating lease liabilities	——	$0+100%	-$15K+89.1%	-$45K+47.7%	-$42K+50.0%
Debt issuance costs and discount amortization	$11.98M+3,392%	$343K—	$343K—	$343K—	$343K—
Net cash from operating activities	-$10.18M-813%	-$3.02M-537%	-$5.02M-237%	-$1.28M+13.7%	-$1.12M+15.1%
Proceeds from maturities/sales of investments	$10.19M—	——	——	——	——
Proceeds from sales of equity securities	$25K—	——	——	——	——
Net cash from investing activities	-$1.5M—	-$24.47M—	——	——	——
Proceeds from issuance of debt	——	$11.34M—	$11.34M—	$11.34M—	$11.34M—
Repayments of debt	——	$2.01M—	$2.01M—	$2.01M—	$2.01M—
Proceeds from issuance of common stock	$37.18K-95.5%	——	——	——	$818K-21.3%
Net cash from financing activities	-$1.64M-135%	$36.78M+3,677,900%	$13.4M—	$0-100%	$4.7M+205%
Effect of exchange rate changes on cash	-$141K—	-$17K—	——	——	——
Net increase (decrease) in cash	-$13.46M-475%	$9.27M+2,060%	$8.23M+652%	$0-100%	$3.59M+1,486%
Interest paid	$403K—	——	——	——	——
Income taxes paid	——	——	——	——	——
Stock-based compensation	$25.37M+1,123%	$48.82M—	$842K-44.5%	$5.37M+21.2%	$2.07M+95.5%
Amortization Of Debt Discount Premium	$11.98M+3,392%	$343K—	$343K—	$343K—	$343K—
Change In Fair Value Of Convertible Debenture Embedded Derivative	——	-$1.75M—	-$1.75M—	-$1.75M—	-$1.75M—
Change In Fair Value Of Embedded Derivative	-$497K—	——	——	——	——
Change In Fair Value Of Exchangeable Shares Derivative Liability	——	$97.42M—	$97.42M—	$97.42M—	$97.42M—
Fair Value Of Liability Warrants Reclassified From Permanent Equity	——	$2.01M—	$2.01M—	$2.01M—	$2.01M—
Gain On Settlement And Extinguishment Of Accounts Payable	——	——	——	——	-$199K—
Increase Decrease In Change In Net Investment In Leases	——	$3.25K—	$3.25K—	$3.25K—	$3.25K—
Increase (Decrease) in Leasing Receivables	——	——	——	——	-$17K+32.0%
Operating lease liabilities	——	$0+100%	-$15K+89.1%	-$45K+47.7%	-$42K+50.0%
Increase (Decrease) in Prepaid Expense	$1.93M+2,663%	——	$1.99M+3,998%	——	$70K—
Increase Decrease In Sales Tax Receivable	-$9K—	-$11K—	——	——	——
Net realized gains (losses)	-$119K—	——	——	——	——
Warrant Modification Expense	——	——	——	——	——
Payments For Gold Held As Longterm Investment	——	$6.12M—	$6.12M—	$6.12M—	$6.12M—
Payments To Acquire Mining Assets	$14.23M—	——	——	——	——
Sale of investments	$10.19M—	——	——	——	——
Sales of and distributions from equity method investments	$25K—	——	——	——	——
Proceeds From Sale Of Gold	$26.41M—	——	——	——	——
Net proceeds from sales of subsidiary shares	$37.18M—	——	——	——	——
Proceeds From Issuance Of Sale Of Equity	$225K—	——	——	——	——
Proceeds From Sale Of Common Stock Under Atthemarket Offerings Net Of Issuance Costs	——	——	——	——	$3.88M—
Repayment Of Convertible Debentures	$38.5M—	——	——	——	——
Repayment Of Finance Obligation	$546K—	$536K—	——	——	——
Repayments of Debt	——	$2.01M—	$2.01M—	$2.01M—	$2.01M—
Common Stock Issued In Settlement Of Accounts Payable And Accrued Expenses	——	$170.75K+460%	$170.75K+460%	$170.75K+460%	$170.75K+460%
Common Stock Issued In Settlement Of Accounts Payable	——	——	——	——	$189K—
Conversion Of Convertible Debentures Into Common Stock	$15.76M—	——	——	——	——
Dividend Payable On Preferred Stock Charged To Additional Paidincapital	$2K0.0%	——	——	——	$2K—
Investment Acquired Through Issuance Of Common Stock	——	$2.62M—	$2.62M—	$2.62M—	$2.62M—
Prepaid Stock Based Compensation	——	$3.75M—	$3.75M—	$3.75M—	$3.75M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioSig Technologies, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?: BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?: Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.